Medical Devices Australia

Australia Tinnitus Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Tinnitus Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $11.2 Mn Placeholder estimate
Estimate 2025 $12.1 Mn 1.2% of the global market
Projected 2034 $25.5 Mn 110.1% Adds $13.4 Mn over 9 forecast years
CAGR 2025–2034 8.6% Faster than 31% of 193 Medical Devices markets here
Key players 5
  • Australia is 1.18% of the global market.
  • In APAC, the largest is China at $74.3 Mn.
  • Fastest growing: India at 10% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$13.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Tinnitus Treatment Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $11.2 Mn — —
2025 (base) $12.1 Mn +$1.0 Mn —
2026 (forecast) $13.2 Mn +$1.0 Mn +8.6%
2027 (forecast) $14.3 Mn +$1.1 Mn +17.9%
2028 (forecast) $15.6 Mn +$1.2 Mn +28.1%
2029 (forecast) $16.9 Mn +$1.3 Mn +39.1%
2030 (forecast) $18.4 Mn +$1.5 Mn +51.1%
2031 (forecast) $19.9 Mn +$1.6 Mn +64.1%
2032 (forecast) $21.6 Mn +$1.7 Mn +78.2%
2033 (forecast) $23.5 Mn +$1.9 Mn +93.5%
2034 (forecast) $25.5 Mn +$2.0 Mn +110.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Tinnitus Treatment Market Analysis at a glance
Market size, 2025$12.1 Mn placeholder estimate
Forecast, 2034$25.5 Mn placeholder estimate
Growth (CAGR), 2025–20348.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, channel and end user (see all)
Key playersNeuromod Devices, Sonova Holding AG, GN Store Nord, Oto Health, Widex (WS Audiology) (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Tinnitus Treatment Market Analysis Executive Summary

Tinnitus treatments help people live with ringing in the ears, using sound therapy, counselling apps and nerve stimulation devices.

Key segments of the tinnitus Treatment market include treatment (Sound Therapy Devices, Bimodal Neuromodulation and Digital CBT Apps) and channel (Audiology Clinics and Online).

Bar chart: Australia Tinnitus Treatment market size, 2024–2034, placeholder estimates. $11.2 Mn in 2024, $12.1 Mn in 2025 and $25.5 Mn in 2034, 8.6% CAGR.
Australia Tinnitus Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Tinnitus Treatment Market Dynamics

Market Growth Drivers

An ageing population, more screening, better implant technology and greater awareness of hearing and child health needs are driving the tinnitus Treatment market.

Opportunity

Over-the-counter options, tele-audiology and programmes in emerging markets give the tinnitus Treatment market room to grow.

Market Restraints

High costs, limited insurance coverage and a shortage of specialists hold back the tinnitus Treatment market.

Competitive Landscape for Tinnitus Treatment Market in Australia

The tinnitus Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tinnitus Treatment Market in Australia

Tinnitus Treatment in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tinnitus Treatment products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tinnitus Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tinnitus Treatment in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 4th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Tinnitus Treatment market in Australia?
Placeholder estimate: about $12.1 Mn in 2025, rising to about $25.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Tinnitus Treatment market in Australia growing?
Placeholder estimate: about 8.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Tinnitus Treatment market report cover?
The report splits the market by treatment (Sound Therapy Devices, Bimodal Neuromodulation, Digital CBT Apps, Hearing Aids), channel (Audiology Clinics, Online) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Tinnitus Treatment market?
Key players include Neuromod Devices, Sonova Holding AG, GN Store Nord, Oto Health and Widex (WS Audiology).
What is driving the Tinnitus Treatment market?
An ageing population, more screening, better implant technology and greater awareness of hearing and child health needs are driving the tinnitus Treatment market.
Who regulates Tinnitus Treatment in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on Tinnitus Treatment?
PubMed lists 149 papers on Tinnitus Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on hearing and mental health

See the topic